Diperoxochloric acid - DermaTools

Drug Profile

Diperoxochloric acid - DermaTools

Alternative Names: CL05; DermaPro; DPOCL; Woxheal

Latest Information Update: 14 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator DermaTools
  • Developer Centaur Pharmaceuticals
  • Class Antiulcers; Disinfectants; Small molecules
  • Mechanism of Action Cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Diabetic foot ulcer
  • Phase II/III Leg ulcer
  • Discontinued Burns

Most Recent Events

  • 07 Jun 2018 DermaTools initiates enrolment in a phase II trial for Diabetic foot ulcers in Germany (EudraCT2017-004527-67)
  • 09 Aug 2017 CytoTools plans a phase II/III trial for Venous leg ulcer in Europe (Intralesional) (CytoTools pipeline, August 2017)
  • 09 Aug 2017 CytoTools plans a phase III trial for Diabetic foot ulcer in Europe (Intralesional) (CytoTools pipeline, August 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top